NM_000274.4:c.272G>A
Variant summary
Our verdict is Pathogenic. The variant received 10 ACMG points: 10P and 0B. PM1PM2PP2PP3_StrongPP5
The NM_000274.4(OAT):c.272G>A(p.Gly91Glu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000062 in 1,613,842 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_000274.4 missense
Scores
Clinical Significance
Conservation
Publications
- ornithine aminotransferase deficiencyInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), G2P, Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 10 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OAT | NM_000274.4 | c.272G>A | p.Gly91Glu | missense_variant | Exon 3 of 10 | ENST00000368845.6 | NP_000265.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 152082Hom.: 0 Cov.: 31 show subpopulations
GnomAD2 exomes AF: 0.0000159 AC: 4AN: 251380 AF XY: 0.0000221 show subpopulations
GnomAD4 exome AF: 0.00000547 AC: 8AN: 1461642Hom.: 0 Cov.: 31 AF XY: 0.0000110 AC XY: 8AN XY: 727134 show subpopulations
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152200Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 74394 show subpopulations
ClinVar
Submissions by phenotype
Ornithine aminotransferase deficiency Pathogenic:3
- -
- -
This sequence change replaces glycine, which is neutral and non-polar, with glutamic acid, which is acidic and polar, at codon 91 of the OAT protein (p.Gly91Glu). This variant is present in population databases (rs386833603, gnomAD 0.01%). This missense change has been observed in individual(s) with gyrate atrophy (PMID: 22182799; Invitae). ClinVar contains an entry for this variant (Variation ID: 56121). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt OAT protein function with a positive predictive value of 80%. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. -
OAT-related disorder Pathogenic:1
The OAT c.272G>A variant is predicted to result in the amino acid substitution p.Gly91Glu. This variant has been reported in the homozygous and presumed compound heterozygous states in individuals with gyrate atrophy of the choroid and retina (GACR) (Sergouniotis et al. 2012. PubMed ID: 22182799; Table S1, Stone et al. 2017. PubMed ID: 28559085). This variant has also been reported in the homozygous state in a large cohort study of retinal disease (Table S1, Lin et al. 2024. PubMed ID: 38219857). This variant has also been observed in the compound heterozygous state in an individual with a metabolic profile showing severely elevated ornithine levels (PreventionGenetics internal data). This variant is reported in 0.013% of alleles in individuals of South Asian descent in gnomAD. Given the evidence, we interpret this variant as likely pathogenic. -
not specified Uncertain:1
Variant summary: OAT c.272G>A (p.Gly91Glu) results in a non-conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 1.6e-05 in 251380 control chromosomes (gnomAD). c.272G>A has been reported in the literature as a biallelic genotype in individuals affected with Ornithine Aminotransferase Deficiency (e.g. Sergouniotis_2012, Stone_2018). These data indicate that the variant may be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 22182799, 28559085). One ClinVar submitter has assessed the variant since 2014, and classified the variant as uncertain significance. Based on the evidence outlined above, the variant was classified as VUS-possibly pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at